Purpose: To determine if tissue magnetic susceptibility is a more direct marker of tissue iron content than other MR markers of iron. This study presents the first quantitative, in vivo measurements of the susceptibility of the substantia nigra in patients with Parkinson's disease. Materials and Methods:Nine patients and 11 controls were studied at 7 Tesla. Susceptibility maps were created by inverting the filtered phase maps associated with T2* weighted images.Results: On average, patients showed an increase in susceptibility of the pars compacta compared with controls, which correlates with the predicted increase in brain iron in Parkinson's disease. A rostral-caudal gradient in susceptibility was also observed in controls and patients. PARKINSON's DISEASE (PD) is a common neurodegenerative disease that is associated with dopaminergic cell loss in the substantia nigra (SN). In normal aging or Parkinson's disease, loss of these neurons occurs concurrently with the accumulation of iron, which acts as a nidus for neuronal damage, leading to free radical formation and lipid peroxidation (1). The pars compacta (PC), the medial sub region of the SN, has the greatest concentration of dopaminergic neurons in the SN.There have been several attempts to use MRI to study changes in the SN in PD. Anatomical differences within the borders of the SN have been studied in patients with PD, and an increased latero-medial contrast gradient has been detected (2,3). Reduced fractional anisotropy of water self diffusion, consistent with axonal loss, has also been observed in the SN of PD patients (4-6) and DTI has indicated changes in neuronal connectivity of the SN in patients with PD (3,7).However, most attempts to study PD with MRI have been based on the changes in iron homeostasis in the SN in PD, and the sensitivity of various MRI parameters to iron. In the SN there is a relatively inhomogeneous distribution of iron (8) in the form of ferritin and a heterogeneous distribution of iron within neuromelanin and hemosiderin, which will cause inhomogeneities in the magnetic field within a sample. The transverse relaxation rates, R2 and R2*, decrease with increasing iron concentration, due to spin dephasing in the microscopic field inhomogeneities induced in regions of heterogeneous iron distribution. R2 is sensitive to diffusion in the inhomogeneous magnetic field, whereas R2* is also sensitive to static dephasing in the inhomogeneous field. Increased R2 (9-12) and R2* (10) has been observed in the pars compacta of the SN of patients with PD, particularly on the most affected side. However, some studies do not detect this effect, possibly because the value of R2 measured will depend on the echo time interval in multiple spin-echo sequences, or on the echo time regimen explored in single spin echo sequences, due to the effects of diffusion and exchange. It has been proposed that the field dependence of R2 is a direct measure of ferritin, and using this it was suggested that early onset PD patients had an increase in ferritin in the S...
Computed tomography has been shown to be sensitive in detecting esophageal varices and now less costly to implement in screening. The cost of esophageal rupture in endoscopy and the less costly risk of contrast reaction as well as radiation exposure in CT of the abdomen should be considered when developing a screening paradigm.
Several fibre tracts can be accurately located using conventional Magnetic Resonance Images (MRI) of the human brain, including the corticospinal tract (CST), which appears as a T (1)-weighted hypointense/T (2)-weighted hyperintense patch in the posterior part of the posterior-limb of the internal capsule (PLIC). Here we use high-field MRI (7T) to assess the quantitative MRI properties of the CST at the PLIC level in 22 healthy young male participants. We used three different imaging modalities: the T (1) and T (2) relaxation times (T (1) and T (2)) and the Magnetization Transfer Ratio (MTR). These measurements obtained in the CST were compared with those in the anterior two-thirds of the PLIC. We observed longer T (1) and T (2) and lower MTR in the CST region compared with the adjacent (control) PLIC region. This effect is consistent with the presence of sparsely distributed, large-diameter fibres described in previous histological studies and, as such, might reflect lower myelin density and/or different morphology of fibres in the CST.
At post mortem, the hypopigmented substantia nigra (SN) of Parkinson disease (PD) patients generally shows a decrease in neuromelanin (NM) with an increase in ferritin particularly in dopaminergic neurones. Relaxometry-based MRI methods of assessing iron content in the SN depend on the microscopic distribution of iron. Phase mapping or susceptibility weighted imaging methods are sensitive to the magnetic susceptibility and hence iron content of tissue, but both are affected by the geometrical distortion of the phase information. We hypothesise that susceptibility mapping will provide a more direct, in vivo measure of iron in the brains of PD patients. Nine PD patients and controls were recruited under local ethics approval (05/Q2402/87). High-resolution T2* weighted MRI scans were acquired using a 7-T Philips Achieva MRI scanner. The relative magnetic susceptibility was measured in the manually outlined whole SN and its medial part representing the pars compacta (PC) compared to surrounding white matter. Values were averaged over both sides all slices. Statistical analysis found a significant difference for the PC susceptibility between PD patients and normal control subjects (p=0.042) but not for the whole SN (p=0.18). This is the first demonstration of high-resolution magnetic susceptibility mapping of the SN of PD patients and shows a focal increase in magnetic susceptibility in the PC only, consistent with an increase in iron.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.